The trademark application RELAX Serelaxin Trial Program was filed by Novartis AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on April 24, 2014, and it was registered by office on August 3, 2014 without any oppositions.
The application was filed in English (German was selected as the second language).
The renewal of the trademark was recorded by the office on January 8, 2025.
of the trademark registration was recorded on January 8, 2025. Change of name and address of the trademark registration was recorded on August 20, 2014. Change of name and professional address of the trademark registration was recorded on April 4, 2016. Change of name and address of the trademark registration was recorded on May 4, 2022. Change of name and address of the trademark registration was recorded on May 16, 2022.